Reporting of side effects
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk profile of the medicinal product. All suspected adverse reactions should be reported to HPRA Pharmacovigilance, website www.hpra.ie. Adverse events can also be reported to Novartis preferably at www.novartis.com/report, by emailing [email protected] or by calling (01) 2080 612.
Welcome to the Novartis portal for healthcare professionals registered within Republic of Ireland
This website is intended for healthcare professionals registered within the Republic of Ireland. By entering this website, you are confirming that you are a healthcare professional registered within Republic of Ireland. This website may contain professional resources, therapy area materials and promotional information about Novartis products.